CHIELLINI, GRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 13.148
AS - Asia 6.174
EU - Europa 5.714
SA - Sud America 881
AF - Africa 272
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 7
Totale 26.205
Nazione #
US - Stati Uniti d'America 12.763
IT - Italia 2.152
CN - Cina 1.947
SG - Singapore 1.856
HK - Hong Kong 1.156
SE - Svezia 995
BR - Brasile 732
DE - Germania 539
BG - Bulgaria 473
VN - Vietnam 332
CA - Canada 322
UA - Ucraina 274
TR - Turchia 268
GB - Regno Unito 251
RU - Federazione Russa 203
FI - Finlandia 191
KR - Corea 187
AT - Austria 178
FR - Francia 132
CI - Costa d'Avorio 128
IN - India 125
CH - Svizzera 122
JP - Giappone 55
AR - Argentina 52
BD - Bangladesh 45
PL - Polonia 43
MX - Messico 33
BE - Belgio 30
ZA - Sudafrica 30
IQ - Iraq 27
EC - Ecuador 25
SA - Arabia Saudita 24
ES - Italia 23
MA - Marocco 23
NL - Olanda 23
ID - Indonesia 22
PK - Pakistan 21
SN - Senegal 21
CZ - Repubblica Ceca 19
PE - Perù 17
NG - Nigeria 16
CO - Colombia 15
UZ - Uzbekistan 15
GR - Grecia 13
IR - Iran 13
KE - Kenya 13
VE - Venezuela 13
EG - Egitto 12
AE - Emirati Arabi Uniti 11
IE - Irlanda 10
PY - Paraguay 9
JM - Giamaica 8
TN - Tunisia 8
AZ - Azerbaigian 7
EU - Europa 7
MY - Malesia 7
TW - Taiwan 7
UY - Uruguay 7
AF - Afghanistan, Repubblica islamica di 6
AL - Albania 6
AU - Australia 6
CL - Cile 6
CR - Costa Rica 6
IL - Israele 6
NO - Norvegia 6
OM - Oman 6
PT - Portogallo 6
BJ - Benin 5
DZ - Algeria 5
KZ - Kazakistan 5
NP - Nepal 5
JO - Giordania 4
LT - Lituania 4
PA - Panama 4
PH - Filippine 4
TT - Trinidad e Tobago 4
BY - Bielorussia 3
DO - Repubblica Dominicana 3
LU - Lussemburgo 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
AO - Angola 2
BB - Barbados 2
BO - Bolivia 2
DK - Danimarca 2
ET - Etiopia 2
GY - Guiana 2
HN - Honduras 2
HU - Ungheria 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
LV - Lettonia 2
PS - Palestinian Territory 2
RO - Romania 2
RS - Serbia 2
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
GA - Gabon 1
Totale 26.193
Città #
Woodbridge 1.678
Ann Arbor 1.296
Ashburn 1.230
Hong Kong 1.152
Singapore 1.030
Chandler 831
Houston 808
Fairfield 800
Dallas 725
Milan 669
Santa Clara 600
Sofia 473
Shanghai 425
Beijing 413
Jacksonville 387
Wilmington 342
Serra 306
Seattle 304
New York 294
Ottawa 271
Cambridge 259
Boardman 249
Hefei 230
Princeton 229
Pisa 216
Lawrence 183
Seoul 182
Izmir 173
Los Angeles 168
Nanjing 164
Vienna 163
Medford 156
Abidjan 128
Bern 118
Rome 88
Des Moines 87
Buffalo 84
Frankfurt am Main 84
Dong Ket 81
Dearborn 75
Istanbul 75
Jüchen 70
Redondo Beach 69
Nanchang 65
Ho Chi Minh City 60
London 60
São Paulo 55
Munich 53
Florence 50
San Diego 49
Tokyo 49
Kunming 47
Redwood City 42
Carrara 41
Hanoi 40
Chicago 36
Hebei 36
The Dalles 36
Bremen 35
Pune 35
Ogden 33
Columbus 32
Warsaw 32
Marseille 31
Brussels 30
Norwalk 27
Lucca 26
Jiaxing 25
Council Bluffs 24
Hyderabad 24
Middleton 24
Shenyang 24
Tianjin 24
Boulder 23
Rio de Janeiro 23
Livorno 22
Boston 21
Dakar 21
Nuremberg 21
Turku 21
Brasília 20
Düsseldorf 19
Johannesburg 19
San Jose 19
Belo Horizonte 18
Changsha 18
Falls Church 18
Hangzhou 18
Guangzhou 17
Montreal 17
Phoenix 17
Washington 17
Fuzhou 16
Lagos 16
Nürnberg 16
San Francisco 16
Denver 15
Orange 15
Renton 15
Stockholm 15
Totale 19.003
Nome #
Effects of Thyroid Hormones and their Metabolites on Learning and Memory in Normal and Pathological Conditions 246
A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor 238
Dual inhibition of PDK1 and Aurora Kinase A: an effective strategy to induce differentiation and apoptosis of human glioblastoma multiforme stem cells 207
Memantine prodrug as a new agent for alzheimer’s disease 206
Ultrastructural Localization of Histidine-rich Glycoprotein in Skeletal Muscle Fibers: Colocalization With AMP Deaminase 205
Modulation of Gene Expression by 3-Iodothyronamine: Genetic Evidence for a Lipolytic Pattern 202
3-Iodothyronamine affects calcium handling in rat ventricular cardiomyocytes 200
3-Iodothyronamine modulates sarcoplasmic reticulum calcium release 196
Cardioprotective effect of 3-iodothyronamine in perfused rat heart subjected to ischemia and reperfusion. 195
The [(Methyloxy)imino]methyl Moiety as a Bioisoster of Aryl. A Novel Class of Completely Aliphatic Beta-Adrenergic Receptor Antagonists 192
Stimulation of cardiac trace amine receptors by 3-iodothyronamine modulates tyrosine phosphorylation and induces cardioprotection 190
3-Iodothyronamine as a novel endogenous chemical messenger: tissue distribution and catabolism 182
Stimulation of cardiac trace amine receptors by 3-iodothyronamine modulates tyrosine phosphorylation and induces cardioprotection 181
Conformationally Restrained Analogs of Sympathomimetic Catecholamines. Synthesis, Conformational Analysis, and Adrenergic Activity of Isochroman Derivatives 181
Endogenous TH metabolite 3-iodothyronamine (T1AM) and synthetic thyronamine-like analogues SG-1 and SG-2 induce autophagy in human glioblastoma cells (U-87MG) 180
3-Iodothyronamine as a Novel Endogenous Chemical Messenger: Tissue Distribution and Catabolism. 177
The pleiotropic functionality of endogenous 3-iodothyronamine (T1AM) and synthetic thyronamine-like analogs: a powerful tool to target interlinked diseases such as obesity and neurodegeneration 177
Synthesis and ß-adrenergic properties of (E)-N-[3-(alkylamino)-2- hydroxypropilidene](methyloxy)amines substituted with an aromatic group on their [(methyloxy)imino]methyl moiety (MOIMM): an investigation into the biopharmacological effects of an aryl substitution in the class of MOIM ß-blocking drugs. 175
Cardioprotection by 3-iodothyronamine, a new endogenous chemical messenger 175
Conformationally restrained ß-blocking oxime ethers. 2. Synthesis and ß-adrenergic properties of diastereoisomeric anti and syn 2-(5’-(3’-aryl-substituted)isoxazolidinyl)-N-alkylethanolamines 174
An efficient substitution reaction for the preparation of thyroid hormone analogues 173
3-Iodothyronamine (T(1)AM) induces variation in phosphorylation pattern of tyrosine residues in rat heart 173
New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection 173
(Z)-(Methyloxyiminomethyl)ethanolamines. Effects of the configuration around the iminic double bond on the beta-adrenergic affinity of moim-type beta-adrenergic blocking agents 172
3-iodothyronamine as a potential anti-tumor compound 170
3-Iodothyronamine affects calcium handling in isolated cardiomyocytes 168
Metabolic reprogramming by 3-Iodothyronamine (T1AM): a new perspective to reverse obesity through co-regulation of sirtuin 4 and 6 expression 167
Different configurations of specific thyroid hormone response elements mediate opposite effects of thyroid hormone and GC-1 on gene expression 166
Cardiac effects of trace amines: pharmacological characterization of trace amine-associated receptors 166
Thyroid hormone-sympathetic interaction and adaptive thermogenesis are thyroid hormone receptor isoform-specific 165
In the brain of mice, 3-iodothyronamine (T1AM) is converted into 3-iodothyroacetic acid (TA1) and it is included within the signaling network connecting thyroid hormone metabolites with histamine 165
2-methylene-19-nor-(23S)-25-dehydro-1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone 164
3-Iodothyronamine Modulates Sarcoplasmic Reticulum Calcium Release 163
Synthesis and biological activities of vitamin D-like inhibitors of CYP24 hydroxylase 163
Distribution of exogenous [125I]-3-iodothyronamine in mouse in vivo: relationship with trace amine-associated receptors. 163
Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands 163
Modulation of Cardiac Inotropic State by 3-Iodothyronamine: Evidence for a Novel Signalling Pathway Mediated by Trace Amine-Associated Receptors 161
Design of thyroid hormone receptor antagonists from first principles 161
Endogenous 3-iodothyronamine (T1Am) and synthetic thyronamine-like analog SG-2 act as novel pleiotropic neuroprotective agents through the modulation of SIRT6 161
2-Methylene-(20S,25R)-19,26-Dinor-Vitamin D Analogs 160
New Insights into Bitopic Orthosteric/Allosteric Ligands of Cannabinoid Receptor Type 2 159
Synthesis and ß-Adrenergic Properties Of (Z)-N-[3-(Alkylamino)-2-hydroxypropilidene](aryl-methyloxy)amines: Effects Of The Configuration Around The Methyloxyiminomethyl(MOIM) Double Bond On The Biopharmacological Properties Of MOIM-type ß-Blocking Agents 159
A new signalling pathway mediated by 3-iodothyronamine in rat heart 159
Cardioprotection by ranolazine in perfused rat heart 159
The thyroid hormone receptor-beta agonist GC-1 induces cell proliferation in rat liver and pancreas 157
The importance of stereochemistry on the actions of vitamin D. 156
Administration of 3-Iodothyronamine (T1AM) Affects Gene Expression in the Rat Adipose Tissue Cells. 156
WEIGHT LOSS WITH PRESERVED GLUCOSE HOMEOSTASIS DURING CHRONIC TREATMENT OF OBESE MICE WITH 3-IODOTHYRONAMINE (T1AM): ROLE OF THE SIRTUIN FAMILY 154
Electron microscope localization of A1 adenosine receptors in human neutrophils 153
Cardiac effects of trace amines: Pharmacological characterization of trace amine-associated receptors 153
FLUORESCENT PROBE SPECIFICALLY LABELS A1 ADENOSINE RECEPTOR IN BOVINE CORONARY ARTERY. 152
3-iodothyronamine is a novel endogenous modulator of cardiac inotropic state 152
ADENOSINE RECEPTORS: NEW PERSPECTIVE BY THE USE OF AGONIST-DERIVED MOLECULAR PROBES. 151
Effects of Zofenopril on Cardiac Sarcoplasmic Reticulum Calcium Handling 151
Delivery of thyronamines (Tams) to the brain: A preliminary study 151
New Insights into the Effects of 3-Iodothyronamine (T1AM) on Metabolism in Mice from Cavity Ring Down Spectroscopy (CRDS) 150
Sintesi e proprietà beta-adrenergiche di [(benzilideneammino)ossi] propanolammine orto-ossipropanolammine sostituite chirali, 149
Evaluation of 3-iodothyronamine (T1AM) in cell preparation, tissue homogenates and biological fluids by HPLC-ESI-MS-MS 149
3-Iodothyronamine (T1AM) modifies tyrosine phosphorylation pattern in rat heart 148
3-Iodothyronamine (T1AM) induces variation in the phosphorylation pattern of thyrosine residues in rat heart 148
Synthesis and biological activity of novel thyroid hormone analogues: 5 '-aryl substituted GC-1 derivatives 147
3-Iodothyronamine (T1AM) signalling pathway involves tyrosine phosphorylation in rat heart 147
The TR-beta selective agonist, GC-1, stimulates mitochondrial oxidative processes to a lesser extent than triiodothyronine 147
Tissue Distribution and Cardiac Metabolism of 3-Iodothyronamine 147
A-ring analogs of 1,25-dihydroxyvitamin D-3 146
Development and primary characterization of a human thyroid organoid in vitro model for thyroid metabolism investigation 145
Synthesis and biological properties of 2-methylene-19-nor-25-dehydro-1alpha-hydroxyvitamin D(3)-26,23-lactones--weak agonists 145
3-Iodothyronamine metabolism and functional effects in FRTL5 thyroid cells. 145
SG‐2: A SYNTHETIC ANALOG OF THYROID HORMONE METABOLITE 3‐IODOTHYRONAMINE (T1AM), PREVENTS β‐AMYLOID NEUROTOXICITY IN VITRO 145
Deciphering the potential of 3-iodothyronamine (T1AM) in regulating lipid metabolism 144
Modulation of cardiac inotropic state by 3-iodothyronamine: evidence for a novel signalling pathway mediated by trace amine-associated receptors 143
2-methylene-(20S,25S)-19,26-dinor-vitamin D analogs 143
Recovery of 3-iodothyronamine and derivatives in biological matrices: problems and pitfalls 143
Cardiac effects of thyronamines 141
Removal of the 26-methyl group from 19-nor-1a,25-dihydroxyvitamin D3 markedly reduces in vivo calcemic activity without altering in vitro VDR binding, HL-60 cell differentiation, and transcription. 140
(E)-(ARYLMETHYLENEAMINOXY)ACETAMIDES AS ANALOGS OF NEUROLEPTIC BENZAMIDES - SYNTHESIS AND D-2-DOPAMINERGIC BINDING-AFFINITY 140
Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis 140
Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3-iodothyronamine 139
Optical imaging of mitochondrial redox state in rodent models with 3-iodothyronamine. 138
Quantification of serum 25-hydroxyvitamin D: a comparison among immunoassay, HPLC-UV, and HPLC-MS 137
Cardiac metabolism of 3-iodothyronamine 136
Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function 136
3-Iodothyronamine: a modulator of the hypothalamus-pancreas-thyroid axes in mice 136
A NOVEL HPLC-MS-MS METHOD TO ASSAY TISSUE THYROID HORMONES 136
Synthesis and Biological Evaluation of Cyclopropylamine Vitamin D‐Like CYP24A1 Inhibitors 136
Modulation of cardiac calcium homeostasis by 3-iodothyronamine 136
3-Iodothyronamine cardiac metabolism: new insights resulting from liquid chromatography tandem mass spectrometry analysis 134
2-methylene-19-nor-(23S)-25-dehydro-1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro 1.alpha.-hydroxyvitamin D.sub.3-26,23-lactone 133
Effects of the thyroid hormone derivatives 3-iodothyronamine and thyronamine on rat liver oxidative capacity 133
An Efficient Aequorea victoria Green Fluorescent Protein for Stimulated Emission Depletion Super-Resolution Microscopy 133
New chiral methyloxyiminomethyl(MOIM) beta-adrenergic antagonists. (S)- and (R)-N-[3-(alkylamino)-2-hydroxypropylidene](p-chlorophenylmethyloxy)amines as probes for determining enantiomeric specificity in the class of MOIM-type beta-adrenergic blocking agents 132
Multi-targeted ChEI-copper chelating molecules as neuroprotective agents 132
Modulation of cardiac inotropic state by a novel thyroid hormone analog acting via non genomic mechanism 131
Effects of 3-Iodothyronamine on Sarcoplasmic Reticulum Calcium Release in Rat Heart 131
3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone 130
Release of miconazole from topical PVA matrices: Preliminary in vitro and in vivo data 129
Fluorescent probe specifically labels A1 adenosine receptor in bovine coronay artery 128
3-iodothyronamine is a novel endogenous modulator of cardiac function 128
Effect of 3-iodothyronamine on myocardial calcium homeostasis 128
2-Methylene-(20R,25S)-19,27-Dinor-(22E)-Vitamin D Analogs 128
Totale 15.770
Categoria #
all - tutte 71.723
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.723


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021876 0 0 0 0 0 73 109 140 144 135 72 203
2021/20222.034 36 127 45 133 383 292 43 89 87 86 134 579
2022/20232.682 387 337 192 265 290 373 14 172 446 16 116 74
2023/20242.446 429 278 275 213 346 344 88 75 36 46 50 266
2024/20255.534 36 236 103 264 476 493 501 305 577 827 638 1.078
2025/20264.122 466 869 861 752 601 573 0 0 0 0 0 0
Totale 26.577